Mannucci, E. and Ghetti, G. (2022) “Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy”, Farmeconomia. Health economics and therapeutic pathways, 23(1). doi: 10.7175/fe.v23i1.1539.